health
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
Employers have grappled with soaring demand for GLP-1 drugs such as Ozempic and Wegovy, which can cost thousands of dollars per patient annually.
TL;DR
- Employers are struggling with the increasing demand for GLP-1 drugs.
- Drugs like Ozempic and Wegovy are experiencing soaring demand.
- These medications can cost thousands of dollars per patient annually.